Characteristic | Overall RA | ACPA-positive RA | ACPA-negative RA |
---|---|---|---|
Number of observations | 867 | 653 | 165 |
Age, mean | 51.2 | 51.3 | 51.5 |
Female (%) | 74.1 | 72.1 | 79.2 |
Baseline values, mean | |||
DAS28 | 5.0 | 5.0 | 5.0 |
CRP | 21.0 | 21.9 | 19.1 |
ESR | 27.9 | 29 | 24.2 |
SJC | 7.8 | 7.8 | 8.1 |
TJC | 7.8 | 7.5 | 8.9 |
VAS global health | 54.1 | 53.8 | 54.5 |
VAS pain | 53.5 | 53.4 | 53.5 |
HAQ | 1.0 | 1.0 | 1.0 |
Changes from baseline to follow-up visit, mean | |||
ΔDAS28 | –1.5 | –1.5 | –1.6 |
ΔCRP | –10.2 | –10.4 | –9.3 |
ΔESR | –9.2 | –9.5 | –8.2 |
ΔSJC | –4.9 | –4.8 | –5.3 |
ΔTJC | –4.3 | –4.1 | –4.9 |
ΔVAS global health | –21.1 | –21.7 | –19.2 |
ΔVAS pain | –21.6 | –22.3 | –19.7 |
ΔHAQ | –0.3 | –0.3 | –0.3 |
EULAR response (%) | |||
No | 25.2 | 25.6 | 23.6 |
Moderate | 31.4 | 30.6 | 33.1 |
Good | 43.4 | 43.8 | 43.3 |